InvestorsHub Logo
Followers 272
Posts 8531
Boards Moderated 0
Alias Born 10/05/2010

Re: db7 post# 19

Saturday, 02/08/2014 12:19:58 PM

Saturday, February 08, 2014 12:19:58 PM

Post# of 31
David A. Young appointed as new CEO here.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 5 th , 2014, the Board of Directors of Global Medical REIT (the “Company”) appointed David A. Young as Chief Executive Officer to hold office until the next annual meeting of shareholders and until their successor is duly elected and qualified or until his resignation or removal.

David A. Young is a 35-year veteran of healthcare real estate. Mr. Young was the founder and CEO of Global Medical Realty Trust, which focused on sponsored development and equity lease financing of market leading healthcare real estate. As the Senior Vice Pre sident of Business Development at GE Capital between 2004 and 2008, Mr. Young organized, co-launched and grew GE Capital’s first acute medical real estate financing initiative.

Over the years, Mr. Young has built a strong track record developing several successful NYSE-listed healthcare REITs such as Windrose Medical Properties, the core assets of which he grew from start-up to over US$500 million. He also grew the portfolio of Healthcare Property Investors, Inc. from US$300 million to over US$3.5 billion, and its net earnings from US$27 million to US$91 million, delivering an internal rate of return of 23% per annum over his ten-year tenure.

In serving as CEO, Mr. Young’s role will be to manage the Company’s operations, marketing, and business development. Together with other consultants, he will develop a portfolio of medical and healthcare-related assets in the United States and selected international countries which offer recurring yields.

The board of directors appointed Mr. Young in recognition of his abilities to assist the Company in expanding its business and the contributions he can make to the Company’s strategic direction. Mr. Young has not yet been appointed to any board committees.

The Company has not entered into any compensation arrangements with Mr. Young. With the appointment of Mr. Young as CEO, Mr. Conn Flanigan is resigning as CEO. Mr. Flanigan is not resigning due to any disagreement with the Company, and will continue to serve the Company as Secretary, Acting Chief Financial Officer, and as a member of the Board of Directors.


Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GMRE News